Now online: first independent framework for assessing pharma company action on AMR

Amsterdam, the Netherlands, 24 August, 2017 – Today, the Access to Medicine Foundation publishes the methodology for its 2018 Antimicrobial Resistance Benchmark. It is the first independently developed framework for evaluating how pharmaceutical companies are taking action to limit antimicrobial resistance (AMR). The framework was developed through consultation with stakeholders and experts working in AMR to build consensus on the priorities for pharmaceutical companies in AMR.

Get in touch

Back to top |